Insulin syringe recall
This one sent a bit of a chill down my spine, as I have a number of friends, clients, and acquaintances who are insulin-dependent diabetics. Apparently, a labelling error by Covidien, Ltd. has led to a recall of over 400,000 disposable syringes. The error reportedly could result in insulin doses more than double the intended level. Affected products were apparently sold at Sam’s and Wal-Mart.
I don’t like to play fear-monger, but it seems like this is enough of a danger to insulin-dependent diabetics that getting the word out is a good thing.
David Sugerman
Tags: insulin syringe, product recall, sugerman